Rapidly progressive cataract and iris atrophy during treatment of Acanthamoeba keratitis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 18452764.
- Also identified by DOI 10.1016/j.ophtha.2007.05.054.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To identify characteristics associated with cataract occurring during the course of Acanthamoeba keratitis. Retrospective observational case series. Eighty-one laboratory-confirmed patients with Acanthamoeba keratitis. Review of clinical records. Development of cataract during management of Acanthamoeba keratitis. Rapidly progressive crystalline lens opacification occurred in 9 eyes within 4 to 15 weeks after diagnosis of Acanthamoeba keratitis. Three were associated with inflammatory complications, including anterior scleritis (2 eyes) and iridocyclitis (1 eye). Six others had the abrupt onset of a dense cataract, including 5 with iris atrophy, that occurred during the initial 6 months of therapy with chlorhexidine, a diamidine, and adjunctive corticosteroid. Extracapsular cataract extraction was performed with or after penetrating keratoplasty. Secondary glaucoma developed in 6 of 9 eyes subsequent to iris atrophy (4 eyes) or a cyclitic membrane (2 eyes), and 3 eyes underwent trabeculectomy. Cataract may occur and progress during the management of Acanthamoeba keratitis in association with anterior segment inflammation, iris atrophy, and secondary glaucoma.
Medical subject headings
- Acanthamoeba Keratitis
- Antiprotozoal Agents
- Cataract
- Iris